Amarillo Biosciences, Inc. engages in the development of biologics for the treatment of human and animal diseases. The company owns or licenses five issued patents related to the low-dose oral delivery of interferon; and owns one issued patent on its dietary supplement, Maxisal. It focuses on research for the treatment of human disease indications primarily influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon alpha. Amarillo Biosciences, Inc. was founded in 1984 and is based in Amarillo, Texas.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Phone806-376-1741
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$80,000.00
Profitability
Miscellaneous
Employees3
Next Earnings Date4/21/2020 (Estimated)
OptionableNot Optionable
Amarillo Biosciences (OTCMKTS:AMAR) Frequently Asked Questions
What is Amarillo Biosciences' stock symbol?
Amarillo Biosciences trades on the OTCMKTS under the ticker symbol "AMAR."
How were Amarillo Biosciences' earnings last quarter?
Amarillo Biosciences Inc (OTCMKTS:AMAR) issued its earnings results on Wednesday, November, 14th. The company reported ($0.01) earnings per share for the quarter. The business had revenue of $0.02 million for the quarter. Amarillo Biosciences had a negative return on equity of 428.46% and a negative net margin of 10,718.75%. View Amarillo Biosciences' Earnings History.
When is Amarillo Biosciences' next earnings date?
Has Amarillo Biosciences been receiving favorable news coverage?
Media coverage about AMAR stock has been trending negative this week, InfoTrie Sentiment reports. The research group ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Amarillo Biosciences earned a news impact score of -2.2 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Amarillo Biosciences.
Who are some of Amarillo Biosciences' key competitors?
Some companies that are related to Amarillo Biosciences include Adamis Pharmaceuticals (ADMP), Merrimack Pharmaceuticals (MACK), Iterum Therapeutics (ITRM), Pharmaxis (PXSLY), Humanigen (HGEN), Annovis Bio (ANVS), Evoke Pharma (EVOK), Jaguar Health (JAGX), Bellerophon Therapeutics (BLPH), Moleculin Biotech (MBRX), RegeneRx Biopharmaceuticals (RGRX), Zomedica Pharmaceuticals Corp (NYSEAMERICAN) (ZOM), Alimera Sciences (ALIM), Vistagen Therapeutics (VTGN) and Edesa Biotech (EDSA).
What other stocks do shareholders of Amarillo Biosciences own?
Who are Amarillo Biosciences' key executives?
Amarillo Biosciences' management team includes the folowing people:
- Dr. Stephen T. Chen, Chairman, CEO, Pres, CFO & COO (Age 69)
- Mr. Bernard Cohen, VP of Admin. (Age 66)
- Mr. Edward L. Morris, Gen. Counsel & Sec.
- Dr. Yung-Hsiang Hung, Medical Affairs Director & Consultant
- Dr. Ching-Yuan Lee, Director of R&D and Consultant
How do I buy shares of Amarillo Biosciences?
Shares of AMAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Amarillo Biosciences' stock price today?
One share of AMAR stock can currently be purchased for approximately $0.27.
How big of a company is Amarillo Biosciences?
What is Amarillo Biosciences' official website?
How can I contact Amarillo Biosciences?
Amarillo Biosciences' mailing address is 4134 BUSINESS PARK DRIVE, AMARILLO TX, 79110. The company can be reached via phone at 806-376-1741 or via email at [email protected]
MarketBeat Community Rating for Amarillo Biosciences (OTCMKTS AMAR)
MarketBeat's community ratings are surveys of what our community members think about Amarillo Biosciences and other stocks. Vote "Outperform" if you believe AMAR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMAR will underperform the S&P 500 over the long term. You may vote once every thirty days.
